STERIS Pours $600M Into New North Carolina Manufacturing Hub
STE sits 19% above its 52-week low of $195.14.
Summary
STERIS is committing $600 million to build a new formulated chemistries manufacturing and distribution center in North Carolina. The new 600,000 square foot campus will create 335 jobs and serve as a central hub to produce high-performance infection prevention and contamination control chemistries. This major capital investment signals confidence in long-term demand for its infection prevention and sterilization chemistries. The project will expand production capacity and likely improve supply chain efficiency for its healthcare and life sciences customers. No timeline or expected completion date was provided, but the scale suggests a multi-year buildout. This follows a strong fiscal 2026 where revenue hit $5.94 billion and the company authorized a $1 billion buyback.
At the time of this announcement, STE was trading at $232.85 on NYSE in the Life Sciences sector, with a market capitalization of approximately $22.7B. The 52-week trading range was $195.14 to $269.44. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.